Issuers of listed transferable securities are required to provide
Oslo Stock Exchange with an annual summary of information made
available to the public, cf the Stock Exchange Regulations, section
5-2, §5.
Please find the annual overview for Pronova BioPharma ASA (OSE:
PRON.OL) attached. The overview includes all announcements made
available in 2009.
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.